Literature DB >> 8289331

Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1.

S N Ebert1, D Subramanian, S S Shtrom, I K Chung, D S Parris, M T Muller.   

Abstract

Endogenous host topoisomerase II acts upon herpes simplex virus type 1 (HSV-1) DNA in infected cells (S.N. Ebert, S.S. Shtrom, and M.T. Muller, J. Virol. 56:4059-4066, 1990), and cleavage is directed exclusively at progeny viral DNA while parental DNA is resistant. To evaluate the possibility that HSV-1 induces topoisomerase II activity which could account for the preferential cleavage of progeny viral DNA, we assessed topoisomerase II cleavage activity on cellular and viral DNA substrates before and after the initiation of viral DNA replication. We show that cleavage of a host gene in mock-infected cells was similar to that observed in HSV-1-infected cells, regardless of whether viral DNA replication had occurred. In addition, quantitative measurements revealed comparable amounts of topoisomerase II activity in infected and mock-infected cells; thus, HSV-1 neither induces nor encodes its own type II topoisomerase and cleavages in vivo are due to a preexisting host topoisomerase. Human cells contain two isozymes of topoisomerase II (p170 and p180), encoded by separate genes. Through the use of isozyme-specific antibodies, we demonstrate that only p170 was found to be cross-linked to HSV-1 DNA even though both forms were present at nearly constant levels in HSV-1-infected cells. Immunofluorescence revealed that by 6 h postinfection, p170 becomes redistributed and localized to sites of active viral DNA synthesis. The data suggest that p170 gains preferential access to replicated viral DNA molecules, which explains why topoisomerase II activity is concentrated on progeny DNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289331      PMCID: PMC236539          DOI: 10.1128/JVI.68.2.1010-1020.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

Authors:  F H Drake; G A Hofmann; H F Bartus; M R Mattern; S T Crooke; C K Mirabelli
Journal:  Biochemistry       Date:  1989-10-03       Impact factor: 3.162

2.  Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats.

Authors:  J R Spitzner; I K Chung; M T Muller
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

3.  Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.

Authors:  T D Chung; F H Drake; K B Tan; S R Per; S T Crooke; C K Mirabelli
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  A rapid and quantitative microtiter assay for eukaryotic topoisomerase II.

Authors:  M T Muller; K Helal; S Soisson; J R Spitzner
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

5.  Single-strand DNA cleavages by eukaryotic topoisomerase II.

Authors:  M T Muller; J R Spitzner; J A DiDonato; V B Mehta; K Tsutsui; K Tsutsui
Journal:  Biochemistry       Date:  1988-11-01       Impact factor: 3.162

6.  Decatenation of kinetoplast DNA by topoisomerases.

Authors:  J C Marini; K G Miller; P T Englund
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

7.  Human cytomegalovirus induces expression of cellular topoisomerase II.

Authors:  J D Benson; E S Huang
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.

Authors:  J Schaack; P Schedl; T Shenk
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

9.  Application of a degenerate consensus sequence to quantify recognition sites by vertebrate DNA topoisomerase II.

Authors:  J R Spitzner; M T Muller
Journal:  J Mol Recognit       Date:  1989-09       Impact factor: 2.137

10.  Aggregates of oligo(dG) bind and inhibit topoisomerase II activity and induce formation of large networks.

Authors:  I K Chung; M T Muller
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

View more
  15 in total

1.  Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

Authors:  W E Hobbs; N A DeLuca
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 2.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis.

Authors:  B Grigolo; I Mazzetti; R M Borzì; I D Hickson; M Fabbri; L Fasano; R Meliconi; A Facchini
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

4.  Plasmid-like replicative intermediates of the Epstein-Barr virus lytic origin of DNA replication.

Authors:  R Pfüller; W Hammerschmidt
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  Formation of herpes simplex virus type 1 replication compartments by transfection: requirements and localization to nuclear domain 10.

Authors:  C J Lukonis; S K Weller
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Inhibition of topoisomerase II by ICRF-193 prevents efficient replication of herpes simplex virus type 1.

Authors:  O Hammarsten; X Yao; P Elias
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Identifying Host Factors Associated with DNA Replicated During Virus Infection.

Authors:  Emigdio D Reyes; Katarzyna Kulej; Neha J Pancholi; Lisa N Akhtar; Daphne C Avgousti; Eui Tae Kim; Daniel K Bricker; Lynn A Spruce; Sarah A Koniski; Steven H Seeholzer; Stuart N Isaacs; Benjamin A Garcia; Matthew D Weitzman
Journal:  Mol Cell Proteomics       Date:  2017-10-02       Impact factor: 5.911

8.  Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2.

Authors:  S K Srinivas; J W Sixbey
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.

Authors:  L M Schang; A Rosenberg; P A Schaffer
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication.

Authors:  Travis H Stracker; Geoffrey D Cassell; Peter Ward; Yueh-Ming Loo; Bas van Breukelen; Stacy D Carrington-Lawrence; Robert K Hamatake; Peter C van der Vliet; Sandra K Weller; Thomas Melendy; Matthew D Weitzman
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.